New adaptive brain stimulator could save battery life in Parkinson's patients
NCT ID NCT07106242
First seen Apr 02, 2026 · Last updated Jun 20, 2026 · Updated 6 times
Summary
This study tested a new type of deep brain stimulation (DBS) called adaptive DBS (aDBS) in 25 people with Parkinson's disease. The device automatically adjusts stimulation based on brain signals, unlike standard continuous DBS. The main goal was to see if aDBS uses less total electrical energy. Participants tried both modes to compare energy use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Juntendo University Hospital
Bunkyo-ku, Tokyo, 113-0033, Japan
-
Juntendo University Nerima Hospital
Tokyo, Nerima-ku, 177-8521, Japan
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Adaptive deep brain stimulation (aDBS) device
What this could lead to
If successful, aDBS could make DBS therapy more efficient, potentially reducing battery changes and side effects for people with Parkinson's.
What could go wrong
This is a small, completed study focused on energy use, not symptom improvement. The benefits of aDBS over standard DBS are still uncertain and may not apply to all patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.